[1]Patent:WO2016/123275,2016,A1.Locationinpatent:Page/Pagecolumn34
[1]ACSChemicalNeuroscience,2017,vol.8,p.1873-1879
57268-33-4 | Dantrolene Related Compound B (50 mg) (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone) | AA00EESR | MFCD28369357
733757-93-2 | 1-Methyl-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine hydrochloride | AA00FYGK | MFCD11110674
92012-22-1 | tert-Butyl 2-acetylpyrrolidine-1-carboxylate | AA00H2XK | MFCD16308624
610258-89-4 | (2E)-3-[3-(Chlorosulfonyl)-4-methoxyphenyl]acrylic acid | AA00IAPQ | MFCD06345758
891392-29-3 | 1-(Benzylsulfonyl)piperidine-4-carboxylic acid | AA00JI2U | MFCD09049310
923193-48-0 | 2-(1,3-thiazol-4-ylmethoxy)benzaldehyde | AA019LKL | MFCD08445099
954580-07-5 | 2-nitro-5-(2,2,2-trifluoroethoxy)benzoic acid | AA019UEI | MFCD09740636
20079-35-0 | 3-(5-formylfuran-2-yl)prop-2-enoic acid | AA01B2A6 | MFCD20659952
414910-19-3 | Benzyl 2-(4-fluorophenyl)-4-oxo-3,4-dihydropyridine-1(2H)-carboxylate | AA01D8ML | MFCD11976091
1392231-41-2 | N-DesmethylPropamocarb | AA01E1TT